France· FR:64744321
FIXAPOST 50 microgrammes/ml + 5 mg/ml, collyre en solution
A medicinal product containing maléate de timolol + latanoprost, registered in France by THEA, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MALÉATE DE TIMOLOL + LATANOPROST
- Manufacturer
- THEA
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009302186001 flacon(s) multidose(s) polyéthylène haute densité (PEHD) de 6 ml avec fermeture de sécurité avec pompeEUR 23.89
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Maléate de timolol + latanoprost in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomFixapost 50micrograms/ml / 5mg/ml eye drops 0.2ml unit doseThea Pharmaceuticals Ltd
- CzechiaAKISTAN DUOPharmaselect International Beteiligungs GmbH, Vídeň
- SwedenFixopost 50 mikrogram/ml + 5 mg/ml Ögondroppar, lösningLaboratoires THEA
- GermanyFixaprostLaboratoires Thea
- SpainARUCOM 50 MICROGRAMOS/ML+ 5 MG/ML COLIRIO EN SOLUCIONDr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh
- FinlandDualuxLaboratorios Salvat S.A.
- NetherlandsBekistan 50 microgram/ml + 5 mg/ml, oogdruppels, oplossingPharmaselect International Beteiligungs GmbH
- ItalyDOCLATIMDOC GENERICI S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Akistan Duo, Fixapost
- Belgium · Akistancomb, Fixaprost
- Bulgaria · Akistan Duo, Ксалаком
- Cyprus · Fixaprost, Lataz-Co
- Czechia · Akistan Duo, Fixapost
- Germany · Fixaprost, Latanelb Comp.
- Denmark · Betalataz, Dualux
- Estonia · Fixopost, Latanoprost/Timolol Elvim
- Spain · Combinest Pf, Dualux
- Finland · Dualux, Fixopost
- United Kingdom (Northern Ireland) · Fixapost, Latanoprost / Timolol Eye Drops
- Greece · Fixaprost, Latancom
- Croatia · Fixalpost, Lapovis Plus
- Hungary · Akistan Duo, Huma-Talia
- Ireland · Fixapost, Latanoprost/Timolol Zentiva
- Iceland · Fixopost, Latanostad Comp
- Italy · Doclatim, Droplacomb
- Lithuania · Fixopost, Latanoprost/Timolol Elvim
- Luxembourg · Fixaprost, Latanoprost/Timolol Eg
- Latvia · Fixopost, Latanoprost/Timolol Elvim
- Netherlands · Bekistan, Fixaprost
- Norway · Dualux, Fixopost
- Poland · Akistan Duo, Fixapost
- Portugal · Enicil Duo, Enicil Duofree
- Romania · Fixanpost, Glautan Plus
- Sweden · Dualux, Fixopost
- Slovenia · Akistancomb, Fixalpost
- Slovakia · Akistan Duo, Fixapost
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/98faeaf7-4365-4ac1-831d-f88c10336dc7 GET /v1/drugs/98faeaf7-4365-4ac1-831d-f88c10336dc7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64744321",
"date_amm": "2020-12-02",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "MALÉATE DE TIMOLOL + LATANOPROST",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre en solution",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about maléate de timolol + latanoprost.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.